Saturation genome editing (SGE) is a high-throughput technique that generates all possible nucleotide variants, allowing for a comprehensive exploration of the functional consequences of genetic polymorphisms.
In precision medicine, SGE represents a powerful tool for identifying genetic determinants of disease susceptibility, drug response, and treatment outcomes.
By exhaustively mapping the genotype-phenotype relationships within a given gene, this approach holds immense potential to unlock novel therapeutic targets, optimize drug design, and ultimately improve healthcare outcomes.
Image Credit: Prostock-studio/Shutterstock.com
Saturation Genome Editing: Foundations and Impact
The core concept behind SGE is to comprehensively explore the functional consequences of every possible nucleotide polymorphism within a target gene.
This exhaustive approach enables researchers to identify genetic variations impacting protein structure, function, and cellular phenotype.
By correlating genetic changes with observable phenotypic effects, SGE provides invaluable insights into protein function and the molecular basis of diseases, a fundamental issue when developing precision medicine strategies.
This technique has an immense potential to characterize the functional impact of genetic variation for understanding complex diseases and designing targeted therapies.1
SGE introduces every possible nucleotide variation at a specific genomic locus, accomplished primarily through the CRISPR-Cas9 gene editing system, a molecular tool that allows precise modification of DNA sequences.
By combining CRISPR with synthetic donor DNA templates, researchers can effectively create and analyze libraries of genetic variants.
For instance, this approach has successfully been applied to classify genetic variants of the Breast Cancer-2 (BRCA2) gene, which is particularly abundant in variants of uncertain significance.2
Molecular Mechanisms
SGE is mainly based on the versatile CRISPR-Cas9 genome editing system. CRISPR-Cas9 comprises a guide RNA (gRNA) that directs the Cas9 endonuclease enzyme to a specific DNA sequence.
Cas9 then introduces a double-stranded break, stimulating the cell's DNA repair machinery. Researchers employ synthetic donor DNA templates containing the desired mutations to introduce specific nucleotide changes.
These templates are used during the repair process, guiding the incorporation of the targeted genetic mutations. While CRISPR-Cas9 is the predominant tool, other genome editing techniques like prime editing are emerging as potential alternatives for SGE, offering additional precision and flexibility.3
Following CRISPR-Cas9 mediated cellular repair, high-throughput sequencing platforms enable comprehensive analysis of the resulting mutant library. SGE can be applied to many genes, including but not limited to those involved in drug metabolism, immune response, and disease susceptibility.
By correlating genotype with phenotype, researchers can identify genetic variants linked to disease risk, drug response, or treatment efficacy, paving the way for personalized medicine strategies tailored to individual patients.
Are Biobanks the Future of Precision Medicine?
Techniques for Studying Saturation Genome Editing
SGE relies on distinct biological techniques. High-throughput sequencing is indispensable for characterizing the generated mutant libraries, enabling precise identification and quantification of nucleotide variations.
Bioinformatics is pivotal in analyzing sequencing data, identifying functional variants, and correlating genetic changes with phenotypic outcomes.
Functional assays, such as cell-based or biochemical assays, are employed to assess the impact of different mutations on protein function, cellular behavior, or organismal phenotype. Additionally, screening platforms are crucial for efficient library generation and data collection.
SGE faces several challenges. First, achieving complete saturation of a target locus can be technically demanding, as it requires efficient delivery of CRISPR-Cas9 and donor templates and optimal conditions for homologous recombination.
Off-target effects, i.e., unintended genetic modifications, are a major issue when employing CRISPR-Cas9, thus complicating data interpretation.4
Additionally, the functional characterization of many genetic variants can be resource-intensive and time-consuming.
Finally, the complexity of biological systems often hinders the direct correlation between genetic changes and phenotypic outcomes, as multiple factors can influence gene expression and function.
Therapeutic Implications
SGE has the potential to revolutionize therapeutic strategies across various disease areas. One of the most promising applications is correcting genetic mutations underlying monogenic diseases.5
By introducing precise nucleotides to restore normal gene function, SGE can offer a versatile approach for identifying variants associated with genetically inherited diseases, including cystic fibrosis, sickle cell anemia, and Huntington's disease.
Furthermore, SGE could accelerate drug discovery by identifying genetic variants that confer resistance or sensitivity to specific therapies.
Additionally, SGE might be employed to engineer cells or organisms with enhanced therapeutic properties, such as producing specific proteins or enzymes for enzyme replacement therapies.
Read More on Genetics
Future Directions
The convergence of disciplines will be essential for translating SGE discoveries into clinical benefits. For instance, bioinformatics can be used to develop predictive models for drug response based on SGE data, enabling precision medicine approaches. Integrating clinical data will allow for the validation of findings and the development of personalized treatment strategies.
Conclusion
Saturation genome editing is a transformative technology with the potential to redefine the landscape of precision medicine.
SGE offers unprecedented insights into disease mechanisms and therapeutic targets by systematically exploring the functional consequences of genetic variation.
Overcoming technical challenges and expanding our understanding of gene-environment interactions will be essential for translating SGE discoveries into clinical benefits.
The integration of diverse disciplines under a “saturation” strategy will surely allow researchers to systematically explore the functional landscape of a target gene and uncover the genetic basis of complex traits.
References
- Dace, P., & Findlay, G. M. (2022). Reducing uncertainty in genetic testing with Saturation Genome Editing. Medizinische Genetik, 34(4), 297-304. https://www.degruyter.com/document/doi/10.1515/medgen-2022-2159/html?lang=en
- Sahu, S., Sullivan, T. L., Mitrophanov, A. Y., Galloux, M., Nousome, D., Southon, E., ... & Sharan, S. K. (2023). Saturation genome editing of 11 codons and exon 13 of BRCA2 coupled with chemotherapeutic drug response accurately determines pathogenicity of variants. Plos Genetics, 19(9), e1010940. https://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1010940
- Erwood, S., Bily, T. M., Lequyer, J., Yan, J., Gulati, N., Brewer, R. A., ... & Cohn, R. D. (2022). Saturation variant interpretation using CRISPR prime editing. Nature Biotechnology, 40(6), 885-895. https://www.nature.com/articles/s41587-021-01201-1
- Zhang, X. H., Tee, L. Y., Wang, X. G., Huang, Q. S., & Yang, S. H. (2015). Off-target effects in CRISPR/Cas9-mediated genome engineering. Molecular Therapy-Nucleic Acids, 4. https://pubmed.ncbi.nlm.nih.gov/26575098/
- Prakash, V., Moore, M., & Yáñez-Muñoz, R. J. (2016). Current progress in therapeutic gene editing for monogenic diseases. Molecular Therapy, 24(3), 465-474. https://pubmed.ncbi.nlm.nih.gov/26765770/
Further Reading